Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- PMID: 32194981
- PMCID: PMC7078228
- DOI: 10.1038/s41421-020-0156-0
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Keywords: Autophagy; Transcription.
Conflict of interest statement
Conflict of interestThe authors declare that they have no conflict of interest.
Figures
Comment in
-
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):256-257. doi: 10.1093/ehjcvp/pvaa041. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32347923 Free PMC article. No abstract available.
Similar articles
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237. Clin Infect Dis. 2020. PMID: 32150618 Free PMC article.
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
-
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.Clin Toxicol (Phila). 2021 Jan;59(1):12-23. doi: 10.1080/15563650.2020.1817479. Epub 2020 Sep 22. Clin Toxicol (Phila). 2021. PMID: 32960100 Review.
-
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?Pharmacol Res. 2020 Aug;158:104904. doi: 10.1016/j.phrs.2020.104904. Epub 2020 May 13. Pharmacol Res. 2020. PMID: 32430286 Free PMC article. Review.
-
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.Int J Antimicrob Agents. 2020 May;55(5):105960. doi: 10.1016/j.ijantimicag.2020.105960. Epub 2020 Apr 3. Int J Antimicrob Agents. 2020. PMID: 32251731 Free PMC article.
Cited by
-
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8. Narra J. 2022. PMID: 38449903 Free PMC article. Review.
-
After the Hurricane: Anti-COVID-19 Drugs Development, Molecular Mechanisms of Action and Future Perspectives.Int J Mol Sci. 2024 Jan 6;25(2):739. doi: 10.3390/ijms25020739. Int J Mol Sci. 2024. PMID: 38255813 Free PMC article. Review.
-
Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period.Signal Transduct Target Ther. 2023 Dec 21;8(1):466. doi: 10.1038/s41392-023-01724-w. Signal Transduct Target Ther. 2023. PMID: 38129394 Free PMC article. Review.
-
Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice.Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0105023. doi: 10.1128/aac.01050-23. Epub 2023 Dec 8. Antimicrob Agents Chemother. 2024. PMID: 38063402 Free PMC article.
-
Herbal Compounds Dauricine and Isoliensinine Impede SARS-CoV-2 Viral Entry.Biomedicines. 2023 Oct 27;11(11):2914. doi: 10.3390/biomedicines11112914. Biomedicines. 2023. PMID: 38001915 Free PMC article.
References
-
- Weniger H. Review of side effects and toxicity of chloroquine. Bull. World Health. 1979;79:906.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
